Anhui Anke BioTech Group (300009) — Net Asset Momentum
Anhui Anke BioTech Group (300009) recorded a net asset momentum of 9.3% as of December 2024, with net assets of CN¥4.30 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See operational self-sufficiency of Anhui Anke BioTech Group to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Anhui Anke BioTech Group Net Asset Momentum (2006–2024)
This chart tracks Anhui Anke BioTech Group's year-over-year net asset growth across 19 annual reporting periods from 2006 to 2024. The most recent momentum reading is +9.3%, with net assets of CN¥4.30 Billion CNY as of December 2024. Read Anhui Anke BioTech Group (300009) total liabilities for a breakdown of total debt and financial obligations.
Annual Net Asset History for Anhui Anke BioTech Group (2006–2024)
The table below shows the complete annual net asset history for Anhui Anke BioTech Group from 2006 to 2024, covering 19 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see market cap of Anhui Anke BioTech Group.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | CN¥4.30 Billion | CN¥5.14 Billion | CN¥835.41 Million | ▲ +9.3% |
| 2023 | CN¥3.93 Billion | CN¥4.95 Billion | CN¥1.02 Billion | ▲ +15.6% |
| 2022 | CN¥3.40 Billion | CN¥4.26 Billion | CN¥853.62 Million | ▲ +17.2% |
| 2021 | CN¥2.90 Billion | CN¥3.67 Billion | CN¥765.52 Million | ▼ -0.9% |
| 2020 | CN¥2.93 Billion | CN¥3.50 Billion | CN¥576.29 Million | ▲ +8.5% |
| 2019 | CN¥2.70 Billion | CN¥3.23 Billion | CN¥526.19 Million | ▲ +34.3% |
| 2018 | CN¥2.01 Billion | CN¥2.53 Billion | CN¥515.86 Million | ▲ +14.2% |
| 2017 | CN¥1.76 Billion | CN¥2.25 Billion | CN¥493.73 Million | ▲ +23.4% |
| 2016 | CN¥1.43 Billion | CN¥1.97 Billion | CN¥539.04 Million | ▲ +12.8% |
| 2015 | CN¥1.26 Billion | CN¥1.40 Billion | CN¥136.82 Million | ▲ +63.5% |
| 2014 | CN¥773.47 Million | CN¥915.58 Million | CN¥142.11 Million | ▲ +17.1% |
| 2013 | CN¥660.60 Million | CN¥749.81 Million | CN¥89.21 Million | ▲ +13.9% |
| 2012 | CN¥580.03 Million | CN¥652.93 Million | CN¥72.91 Million | ▲ +6.6% |
| 2011 | CN¥543.88 Million | CN¥603.65 Million | CN¥59.77 Million | ▲ +4.1% |
| 2010 | CN¥522.30 Million | CN¥589.55 Million | CN¥67.25 Million | ▲ +5.4% |
| 2009 | CN¥495.41 Million | CN¥542.36 Million | CN¥46.95 Million | ▲ +233.3% |
| 2008 | CN¥148.64 Million | CN¥222.96 Million | CN¥74.32 Million | ▲ +8.4% |
| 2007 | CN¥137.09 Million | CN¥236.55 Million | CN¥99.46 Million | ▲ +12.4% |
| 2006 | CN¥122.00 Million | CN¥225.72 Million | CN¥103.72 Million | — |